200 related articles for article (PubMed ID: 38692061)
41. Non-coding RNAs as regulators in epigenetics (Review).
Wei JW; Huang K; Yang C; Kang CS
Oncol Rep; 2017 Jan; 37(1):3-9. PubMed ID: 27841002
[TBL] [Abstract][Full Text] [Related]
42. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
43. Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism.
Wang J; Li L; Xu M; Rong R; Zhu T
Transplantation; 2013 Nov; 96(9):774-81. PubMed ID: 23900211
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic modifications of histones during osteoblast differentiation.
Adithya SP; Balagangadharan K; Selvamurugan N
Biochim Biophys Acta Gene Regul Mech; 2022 Jan; 1865(1):194780. PubMed ID: 34968769
[TBL] [Abstract][Full Text] [Related]
45. Epigenetics and pharmacology.
Stefanska B; MacEwan DJ
Br J Pharmacol; 2015 Jun; 172(11):2701-4. PubMed ID: 25966315
[TBL] [Abstract][Full Text] [Related]
46. Epigenetics of Skeletal Diseases.
Del Real A; Riancho-Zarrabeitia L; López-Delgado L; Riancho JA
Curr Osteoporos Rep; 2018 Jun; 16(3):246-255. PubMed ID: 29574535
[TBL] [Abstract][Full Text] [Related]
47. Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications.
Liu Y; Leng P; Liu Y; Guo J; Zhou H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555400
[TBL] [Abstract][Full Text] [Related]
48. DNA Methylation and Histone Modification in Dental-derived Mesenchymal Stem Cells.
Zeng B; Liu G; Huang J
Stem Cell Rev Rep; 2022 Dec; 18(8):2797-2816. PubMed ID: 35896859
[TBL] [Abstract][Full Text] [Related]
49. The Role of MicroRNA in Graft-Versus-Host-Disease: A Review.
Pitea M; Canale FA; Porto G; Verduci C; Utano G; Policastro G; Alati C; Santoro L; Imbalzano L; Martino M
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761936
[TBL] [Abstract][Full Text] [Related]
50. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
[TBL] [Abstract][Full Text] [Related]
51. T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor.
Jiang H; Fu D; Bidgoli A; Paczesny S
Front Immunol; 2021; 12():761448. PubMed ID: 34675938
[TBL] [Abstract][Full Text] [Related]
52. Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Wu XL; Zhuang HF; Zhao YN; Yu XL; Dai TY; Gao RL
Chin J Integr Med; 2020 May; 26(5):324-329. PubMed ID: 32350801
[TBL] [Abstract][Full Text] [Related]
53. Current Insights into Oral Cancer Epigenetics.
Irimie AI; Ciocan C; Gulei D; Mehterov N; Atanasov AG; Dudea D; Berindan-Neagoe I
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495520
[TBL] [Abstract][Full Text] [Related]
54. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract][Full Text] [Related]
55. The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia.
Schroeder MA; Choi J; Staser K; DiPersio JF
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1125-1134. PubMed ID: 29289756
[TBL] [Abstract][Full Text] [Related]
56. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
[TBL] [Abstract][Full Text] [Related]
57. Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy.
Varela MA; Roberts TC; Wood MJ
Neurotherapeutics; 2013 Oct; 10(4):621-31. PubMed ID: 24068583
[TBL] [Abstract][Full Text] [Related]
58. Defibrotide combined with triple therapy including posttransplant cyclophosphamide, low dose rabbit anti-t-lymphocyte globulin and cyclosporine is effective in prevention of graft versus host disease after allogeneic peripheral blood stem cell transplantation for hematologic malignancies.
Akpinar S; Kayikci O; Tekgunduz E
Transfus Apher Sci; 2022 Feb; 61(1):103367. PubMed ID: 35120825
[TBL] [Abstract][Full Text] [Related]
59. The FcgammaRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation.
van der Straaten HM; Fijnheer R; Nieuwenhuis HK; van de Winkel JG; Verdonck LF
Biol Blood Marrow Transplant; 2005 Mar; 11(3):206-12. PubMed ID: 15744239
[TBL] [Abstract][Full Text] [Related]
60. One-carbon metabolism and epigenetics.
Friso S; Udali S; De Santis D; Choi SW
Mol Aspects Med; 2017 Apr; 54():28-36. PubMed ID: 27876555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
